Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $92.8300 (0.3%) ($91.3100 - $94.4900) on Mon. Aug. 26, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.76% (three month average) | RSI | 54 | Latest Price | $92.8300(0.3%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.9% a day on average for past five trading days. | Weekly Trend | LGND advances 1.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(60%) IWO(57%) XBI(55%) IWC(54%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.38% in a week (0% probabilities). VIXM(-33%) VXX(-20%) TLT(-15%) IFRA(-9%) UUP(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.38% (StdDev 2.76%) | Hourly BBV | 0 () | Intraday Trend | -1.8% | | | |
|
Resistance Level | $93.71 | 5 Day Moving Average | $94.89(-2.17%) | 10 Day Moving Average | $94.6(-1.87%) | 20 Day Moving Average | $93.71(-0.94%) | To recent high | -22.7% | To recent low | 3.7% | Market Cap | $1.492b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |